EUVIMEDEUVIMED entdecken
Crossref

Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study

Daire Hanna, David Propper

Annals of Pancreatic Cancer · 2026-08 · 9 · 22-22

DOI: 10.21037/apc-26-0015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Pancreatic Cancer, 2026-08. Verfasst von Daire Hanna und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hanna, D., & Propper, D. (2026). Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study. Annals of Pancreatic Cancer, 9, 22-22. https://doi.org/10.21037/apc-26-0015

Vancouver

Hanna D, Propper D. Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study. Annals of Pancreatic Cancer. 2026;9:22-22. doi:10.21037/apc-26-0015

BibTeX
@article{Hanna2026,
  author = {Hanna, Daire and Propper, David},
  title = {Perioperative therapy for resectable and borderline resectable pancreatic adenocarcinoma: interpreting the AGICC study},
  journal = {Annals of Pancreatic Cancer},
  year = {2026},
  volume = {9},
  pages = {22--22},
  doi = {10.21037/apc-26-0015}
}
Kostenlos starten →